Between September 2019 and December 2021, 20 patients referred with suspected acute TTP were found to demonstrate a discrepancy in ADAMTS13 activity results between the AcuStar® and ELISA assay methods. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.